These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36727247)

  • 1. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials.
    Barker TH; Stone JC; Sears K; Klugar M; Tufanaru C; Leonardi-Bee J; Aromataris E; Munn Z
    JBI Evid Synth; 2023 Mar; 21(3):494-506. PubMed ID: 36727247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies.
    Barker TH; Habibi N; Aromataris E; Stone JC; Leonardi-Bee J; Sears K; Hasanoff S; Klugar M; Tufanaru C; Moola S; Munn Z
    JBI Evid Synth; 2024 Mar; 22(3):378-388. PubMed ID: 38287725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process.
    Barker TH; Stone JC; Sears K; Klugar M; Leonardi-Bee J; Tufanaru C; Aromataris E; Munn Z
    JBI Evid Synth; 2023 Mar; 21(3):478-493. PubMed ID: 36121230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies.
    Barker TH; Hasanoff S; Aromataris E; Stone J; Leonardi-Bee J; Sears K; Habibi N; Klugar M; Tufanaru C; Moola S; Liu XL; Munn Z
    JBI Evid Synth; 2024 Aug; ():. PubMed ID: 39177422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.
    Zeng X; Zhang Y; Kwong JS; Zhang C; Li S; Sun F; Niu Y; Du L
    J Evid Based Med; 2015 Feb; 8(1):2-10. PubMed ID: 25594108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.
    Munn Z; Barker TH; Moola S; Tufanaru C; Stern C; McArthur A; Stephenson M; Aromataris E
    JBI Evid Synth; 2020 Oct; 18(10):2127-2133. PubMed ID: 33038125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews.
    Munn Z; Stone JC; Aromataris E; Klugar M; Sears K; Leonardi-Bee J; Barker TH
    JBI Evid Synth; 2023 Mar; 21(3):467-471. PubMed ID: 36476419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical appraisal of nonrandomized studies-A review of recommended and commonly used tools.
    Quigley JM; Thompson JC; Halfpenny NJ; Scott DA
    J Eval Clin Pract; 2019 Feb; 25(1):44-52. PubMed ID: 29484779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk related to bias assessment: (4) Revised Cochrane Risk of Bias Tool for cluster-randomized control trials (RoB2.0)].
    Lyu XZ; Sun F; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):240-244. PubMed ID: 29495213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk on bias assessment: (2) Revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0)].
    Yang ZR; Sun F; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1285-1291. PubMed ID: 28910948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From critical appraisal to risk of bias assessment: clarifying the terminology for study evaluation in JBI systematic reviews.
    Stone JC; Barker TH; Aromataris E; Ritskes-Hoitinga M; Sears K; Klugar M; Leonardi-Bee J; Munn Z
    JBI Evid Synth; 2023 Mar; 21(3):472-477. PubMed ID: 36882947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Dietary Interventions in Prevention and Treatment of Iron-Deficiency Anemia in Pregnant Women: A Systematic Review of Randomized Controlled Trials.
    Skolmowska D; Głąbska D; Kołota A; Guzek D
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of interventions to meet family needs of critically ill patients in an adult intensive care unit: a systematic review update.
    Kynoch K; Chang A; Coyer F; McArdle A
    JBI Database System Rev Implement Rep; 2016 Mar; 14(3):181-234. PubMed ID: 27532144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of the Risk of Bias 2 Tool].
    Lee LL
    Hu Li Za Zhi; 2021 Apr; 68(2):85-91. PubMed ID: 33792022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bias risk assessment: (3) Revised Cochrane bias risk assessment tool for individual randomized, cross-over trials (RoB2.0)].
    Wu SS; Sun F; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1436-1440. PubMed ID: 29060995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JBI series paper 2: tailored evidence synthesis approaches are required to answer diverse questions: a pragmatic evidence synthesis toolkit from JBI.
    Aromataris E; Stern C; Lockwood C; Barker TH; Klugar M; Jadotte Y; Evans C; Ross-White A; Lizarondo L; Stephenson M; McArthur A; Jordan Z; Munn Z
    J Clin Epidemiol; 2022 Oct; 150():196-202. PubMed ID: 35429608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.